Aarti Drugs (India) Buy Hold or Sell Recommendation
| AARTIDRUGS | 500.75 0.90 0.18% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding Aarti Drugs Limited is 'Cautious Hold'. Macroaxis provides Aarti Drugs buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AARTIDRUGS positions. The advice algorithm takes into account all of Aarti Drugs' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Aarti Drugs' buy or sell advice are summarized below:
Real Value 415.31 | Hype Value 499.85 | Market Value 500.75 | Naive Value 466.98 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Aarti Drugs Limited given historical horizon and risk tolerance towards Aarti Drugs. When Macroaxis issues a 'buy' or 'sell' recommendation for Aarti Drugs Limited, the advice is generated through an automated system that utilizes algorithms and statistical models.
Aarti |
Execute Aarti Drugs Buy or Sell Advice
The Aarti recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aarti Drugs Limited. Macroaxis does not own or have any residual interests in Aarti Drugs Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aarti Drugs' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Aarti Drugs Trading Alerts and Improvement Suggestions
| About 63.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Aarti Drugs receives five observations in Form 483 from USFDA for its Himachal Pradesh facility - Upstox |
Aarti Drugs Returns Distribution Density
The distribution of Aarti Drugs' historical returns is an attempt to chart the uncertainty of Aarti Drugs' future price movements. The chart of the probability distribution of Aarti Drugs daily returns describes the distribution of returns around its average expected value. We use Aarti Drugs Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aarti Drugs returns is essential to provide solid investment advice for Aarti Drugs.
| Mean Return | -0.07 | Value At Risk | -2.98 | Potential Upside | 2.75 | Standard Deviation | 1.92 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aarti Drugs historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aarti Drugs Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (786.9M) | (891.8M) | (1.1B) | 58.2M | 52.4M | 55.0M | |
| Change In Cash | 21.3M | 20.4M | 128.0M | (132.3M) | (152.1M) | (144.5M) | |
| Free Cash Flow | 2.0B | 667.2M | (823.4M) | (304.7M) | (350.4M) | (332.9M) | |
| Depreciation | 487.5M | 498.8M | 500.5M | 503.2M | 578.7M | 356.6M | |
| Other Non Cash Items | (27.9M) | (779.6M) | (630.2M) | (248.4M) | (223.6M) | (212.4M) | |
| Dividends Paid | 70.3M | 232.1M | 95.1M | 94M | 108.1M | 104.9M | |
| Capital Expenditures | 479.9M | 881.3M | 1.5B | 1.6B | 1.9B | 2.0B | |
| Net Income | 1.9B | 3.7B | 2.7B | 2.2B | 2.6B | 2.7B | |
| End Period Cash Flow | 67.7M | 88.1M | 216.1M | 83.8M | 96.4M | 67.8M | |
| Net Borrowings | (1.5B) | (349.7M) | 2.0B | 613.7M | 705.8M | 741.1M | |
| Change To Netincome | 411.0M | 106.5M | 19.0M | 330.3M | 297.2M | 284.1M |
Aarti Drugs Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aarti Drugs or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aarti Drugs' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aarti stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.12 | |
β | Beta against NYSE Composite | 0.39 | |
σ | Overall volatility | 1.88 | |
Ir | Information ratio | -0.09 |
Aarti Drugs Volatility Alert
Aarti Drugs Limited exhibits very low volatility with skewness of 0.26 and kurtosis of 1.36. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aarti Drugs' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aarti Drugs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Aarti Drugs Fundamentals Vs Peers
Comparing Aarti Drugs' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aarti Drugs' direct or indirect competition across all of the common fundamentals between Aarti Drugs and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aarti Drugs or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aarti Drugs' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aarti Drugs by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aarti Drugs to competition |
| Fundamentals | Aarti Drugs | Peer Average |
| Return On Equity | 0.16 | -0.31 |
| Return On Asset | 0.0749 | -0.14 |
| Profit Margin | 0.07 % | (1.27) % |
| Operating Margin | 0.1 % | (5.51) % |
| Current Valuation | 51.58 B | 16.62 B |
| Shares Outstanding | 91.94 M | 571.82 M |
| Shares Owned By Insiders | 63.07 % | 10.09 % |
| Shares Owned By Institutions | 6.47 % | 39.21 % |
| Price To Book | 3.83 X | 9.51 X |
| Price To Sales | 1.75 X | 11.42 X |
| Revenue | 27.16 B | 9.43 B |
| Gross Profit | 8.06 B | 27.38 B |
| EBITDA | 3.08 B | 3.9 B |
| Net Income | 2.24 B | 570.98 M |
| Total Debt | 6.09 B | 5.32 B |
| Book Value Per Share | 131.06 X | 1.93 K |
| Cash Flow From Operations | 1.34 B | 971.22 M |
| Earnings Per Share | 19.54 X | 3.12 X |
| Number Of Employees | 1 K | 18.84 K |
| Beta | 0.88 | -0.15 |
| Market Capitalization | 45.95 B | 19.03 B |
| Total Asset | 24.21 B | 29.47 B |
| Retained Earnings | 10.21 B | 9.33 B |
| Working Capital | 5.59 B | 1.48 B |
| Annual Yield | 0 % | |
| Net Asset | 24.21 B | |
| Last Dividend Paid | 1.0 |
Aarti Drugs Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aarti . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Aarti Drugs Buy or Sell Advice
When is the right time to buy or sell Aarti Drugs Limited? Buying financial instruments such as Aarti Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 5.4B | 6.1B | 7.0B | 4.0B | Total Assets | 22.1B | 24.2B | 27.8B | 29.2B |
Use Investing Ideas to Build Portfolios
In addition to having Aarti Drugs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banks Thematic Idea Now
Banks
Large and small money and credit banks and credit services. The Banks theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Aarti Drugs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Aarti Stock analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |